Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Alembic Pharmaceuticals Limited ( (IN:APLLTD) ) is now available.
Alembic Pharmaceuticals Limited announced the successful completion of a scheduled Good Manufacturing Practice (GMP) inspection by the United States Food and Drug Administration (USFDA) at its API-III Facility in Karakhadi. The inspection, which took place from March 17 to March 21, 2025, concluded without any Form 483 observations, indicating full compliance with USFDA standards. This achievement underscores Alembic’s commitment to maintaining high-quality standards and could enhance its reputation and reliability in the global pharmaceutical market.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs) and formulations. The company is known for its emphasis on quality and compliance with international standards, serving both domestic and international markets.
YTD Price Performance: -19.71%
Average Trading Volume: 5,427
Current Market Cap: 164.2B INR
Learn more about APLLTD stock on TipRanks’ Stock Analysis page.